Neuland Laboratories Stock

Neuland Laboratories Equity

The The Equity of Neuland Laboratories (NEULANDLAB.NS) as of Aug 25, 2026 is 15.25 B INR. In the previous year, The Equity was 12.83 B INR — a change of 18.87% (higher).

Equity

15.25 BINR

YoY

18.87%

Last updated:

In 2026, Neuland Laboratories's equity was 15.25 B INR, a 18.87% increase from the 12.83 B INR equity in the previous year.

The Neuland Laboratories Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
5.58 B INR
Jan 1, 2019
6.99 B INR
Jan 1, 2020
7.10 B INR
Jan 1, 2021
7.87 B INR
Jan 1, 2022
8.41 B INR
Jan 1, 2023
9.94 B INR
Jan 1, 2024
12.83 B INR
Jan 1, 2025
15.25 B INR
The Neuland Laboratories Equity history
YEAREquityYoY
15.25 BINR+18.87%
12.83 BINR+29.03%
9.94 BINR+18.27%
8.41 BINR+6.87%
7.87 BINR+10.77%
7.10 BINR+1.53%
6.99 BINR+25.32%
5.58 BINR+2.27%
5.46 BINR+9.14%
5.00 BINR+209.73%
1.61 BINR+30.16%
1.24 BINR—
Access this data via the Eulerpool API
Get Free API Key

Neuland Laboratories Stock analysis

What does Neuland Laboratories do? Neuland Laboratories is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Neuland Laboratories's Equity

Neuland Laboratories's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Neuland Laboratories's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Neuland Laboratories's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Neuland Laboratories's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Neuland Laboratories’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Neuland Laboratories stock

The Equity of Neuland Laboratories is 15.25 B INR in 2026.

The Equity of Neuland Laboratories changed from 12.83 B INR to 15.25 B INR, representing a 18.87% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Neuland Laboratories since 2006 – with annual values, charts, and detailed analysis.

The Equity's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Neuland Laboratories historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Neuland Laboratories

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Neuland Laboratories